Press Releases

Structured Immunity and Medigene Announce Collaboration Aimed at Improving T Cell Receptor Development

Structured Immunity to evaluate specificity and recognition properties of a lead T cell receptor using proprietary structural immunology platform SOUTH BEND, IN. and PLANEGG/MARTINSRIED, Germany, Aug. 21, 2018 – Structured Immunity, a biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins and Medigene AG, a leading biotechnology company engaged in […]

Read More